BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6612619)

  • 1. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV; Sokolovskaia IV; Gonchar NA
    Ter Arkh; 1983; 55(6):39-41. PubMed ID: 6612619
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical assessment of lipid free-radical oxidation in chronic glomerulonephritis patients].
    Nazar PS; Galitskiĭ IaD; Martyniuk ES
    Ter Arkh; 1987; 59(9):104-6. PubMed ID: 3424171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma lipids in patients with chronic glomerulonephritis].
    Kolmakova EV
    Urol Nefrol (Mosk); 1990; (1):16-9. PubMed ID: 2336751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI; Kulikova AI; Tugusheva FA; Zubina IM; Kozlov VV
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome].
    Shishkin AN; Kolmakova EV; Ashirova KV
    Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the serum lipid spectrum of glomerulonephritis patients].
    Nikulina GG; Petrun' NM; Pyrig LA; Mel'man NIa
    Vrach Delo; 1985 Oct; (10):20-4. PubMed ID: 4090424
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic significance of the state of the fibrinolytic system and evaluation of its functional possibilities in nephrotic syndrome].
    Poliantseva LR; Podorol'skaia LV; Nevraeva OG; Andreenko GV
    Ter Arkh; 1978; 50(11):84-91. PubMed ID: 725768
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the lipid and fatty acid composition of the blood serum in subjects with glomerulonephrits with the nephrotic syndrome].
    Pisano L; Lombardi D; Spanò G
    Boll Soc Ital Cardiol; 1967; 12(1):27-36. PubMed ID: 5596746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood volumes in patients with chronic glomerulonephritis].
    Diadyk AI; Siniachenko OV; Bagriĭ AE; Iarovaia NF; Shchukina EV
    Ter Arkh; 1992; 64(12):94-6. PubMed ID: 1292145
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein Z and vitamin K in kidney disease.
    Małyszko JS; Małyszko J; Skrzydlewska E; Pawlak K; Myśliwiec M
    Rocz Akad Med Bialymst; 2004; 49():197-200. PubMed ID: 15631343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the thrombocyte and plasma factors of hemostasis in amyloidosis].
    Charyev BM; Kozlovskaia LV; Mishchenko AL; Kozlovskaia NL; Karryeva BCh
    Ter Arkh; 1990; 62(6):75-9. PubMed ID: 2218933
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on plasma active and inactive renins in patients with nephrotic syndrome. Part II. Plasma active and inactive in glomerulonephritis with and without nephrotic syndrome (author's transl)].
    Tsai TJ
    Taiwan Yi Xue Hui Za Zhi; 1981 Jun; 80(6):592-9. PubMed ID: 7033441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Functional status of the hemostatic and fibrinolytic systems in patients with clinical variants of chronic glomerulonephritis].
    Miagkov II; Nazar PS
    Ter Arkh; 1989; 61(11):123-6. PubMed ID: 2633374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in some parameters of complement system function in childhood nephropathies].
    Brai M; Amato G; Balsamo V; Brai M
    Minerva Pediatr; 1977 Mar; 29(8):529-32. PubMed ID: 865432
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of plasma proteins in various renal diseases--with special reference to the changes in acute phase reactants of nephrotic syndrome (N.S.)].
    Ito A; Okura T
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1217-26. PubMed ID: 7166888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Platelet aggregation and the fibronectin level of the blood in children with chronic glomerulonephritis].
    Pinelis VG; Razdol'kina TI; Sergeeva TV; Gozalishvili TV; Storozhevykh TP; Tsygin AN
    Urol Nefrol (Mosk); 1995; (4):17-9. PubMed ID: 7571193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombotic therapy in correcting hemostatic disorders in patients with chronic glomerulonephritis].
    Nazar PS; Badiuk RA
    Vrach Delo; 1990 Mar; (3):18-20. PubMed ID: 2368351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet hypersensitivity in the nephrotic syndrome.
    Remuzzi G; Marchesi D; Mecca G; de Gaetano G; Silver M
    Proc Eur Dial Transplant Assoc; 1979; 16():487-94. PubMed ID: 548992
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of heparin in treating the nephrotic syndrome].
    Vat'ian AA
    Vrach Delo; 1973 May; 5():78-81. PubMed ID: 4757744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.